|
|
||||||||
Published online before print November 11, 2003
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||




* Department of Haematological Medicine, Leukaemia Sciences, Guys, Kings, St. Thomas School of Medicine, Rayne Institute, London, United Kingdom; and
Cancer ResearchUK Labs and Section of Cancer Cell Biology, Imperial College School of Medicine at Hammersmith Hospital, London, United Kingdom
1Correspondence: Department of Haematological Medicine, Leukaemia Sciences, Guys, Kings, St. Thomas School of Medicine, Rayne Institute, 123 Coldharbour Lane, London SE5 9RS, UK. E-mail: nicholas.s.thomas{at}kcl.ac.uk
Cyclin D2 affects B cell proliferation and differentiation in vivo. It is rate-limiting for B cell receptor (BCR)-dependent proliferation of B cells, and cyclin D2-/- mice lack CD5+(B1) B lymphocytes. We show here that the bone marrow (BM) of cyclin D2-/- mice contains half the numbers of Sca1+B220+ B cell progenitors but normal levels of Sca1+ progenitor cells of other lineages. In addition, clonal analysis of BM from the cyclin D2-/- and cyclin D2+/+ mice confirmed that there were fewer B cell progenitors (B220+) in the cyclin D2-/- mice. In addition, the colonies from cyclin D2-/- mice were less mature (CD19lo) than those from cyclin D2+/+ mice (CD19Hi). The number of mature B2 B cells in vivo is the same in cyclin D2-/- and cyclin D2+/+ animals. Lack of cyclin D2 protein may be compensated by cyclin D3, as cyclin-dependent kinase (cdk)6 coimmunoprecipitates with cyclin D3 but not cyclin D1 from BM mononuclear cells of cyclin D2-/- mice. It is active, as endogenous retinoblastoma protein is phosphorylated at the cdk6/4-cyclin D-specific sites, S807/811. We conclude that cyclin D2 is rate-limiting for the production of B lymphoid progenitor cells whose proliferation does not depend on BCR signaling.
Key Words: mouse bone marrow Sca1+ B lymphocytes cellular proliferation
This article has been cited by other articles:
![]() |
J. Klaewsongkram, Y. Yang, S. Golech, J. Katz, K. H. Kaestner, and N.-p. Weng Kruppel-Like Factor 4 Regulates B Cell Number and Activation-Induced B Cell Proliferation J. Immunol., October 1, 2007; 179(7): 4679 - 4684. [Abstract] [Full Text] [PDF] |
||||
![]() |
P.-A. Deglesne, N. Chevallier, R. Letestu, F. Baran-Marszak, T. Beitar, C. Salanoubat, L. Sanhes, J. Nataf, C. Roger, N. Varin-Blank, et al. Survival response to B-cell receptor ligation is restricted to progressive chronic lymphocytic leukemia cells irrespective of zap70 expression. Cancer Res., July 15, 2006; 66(14): 7158 - 7166. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Glennie, I. Soeiro, P. J. Dyson, E. W.-F. Lam, and F. Dazzi Bone marrow mesenchymal stem cells induce division arrest anergy of activated T cells Blood, April 1, 2005; 105(7): 2821 - 2827. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Fernandez de Mattos, A. Essafi, I. Soeiro, A. M. Pietersen, K. U. Birkenkamp, C. S. Edwards, A. Martino, B. H. Nelson, J. M. Francis, M. C. Jones, et al. FoxO3a and BCR-ABL Regulate cyclin D2 Transcription through a STAT5/BCL6-Dependent Mechanism Mol. Cell. Biol., November 15, 2004; 24(22): 10058 - 10071. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. C. Chiles Regulation and Function of Cyclin D2 in B Lymphocyte Subsets J. Immunol., September 1, 2004; 173(5): 2901 - 2907. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |